TRACON Pharmaceuticals, Inc. Proceeds from Common Stock Issued
TRACON Pharmaceuticals, Inc. reported Proceeds from Common Stock Issued of $1.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-08-13
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $2.00K, a 95.65% decline year-over-year.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $46.00K.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2023 was $45.00K, a 52.63% decline from fiscal 2022.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2022 was $95.00K, a 36.24% decline from fiscal 2021.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2021 was $149.00K.
- TRACON Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2015 was $36.20M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.00K 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.00K derived: sum of 2 quarters · filed 2024-03-05 | $45.00K 10-K · filed 2024-03-05 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $43.00K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $43.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $46.00K derived: sum of 2 quarters · filed 2024-03-05 | $81.00K derived: sum of 3 quarters · filed 2024-03-05 | $95.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $35.00K derived: sum of 2 quarters · filed 2023-11-09 | $49.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $49.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $14.00K 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | $149.00K 10-K · filed 2024-03-05 | |||
| 2021-03-31 | -$174.00K 10-Q · filed 2022-05-11 | |||
| 2020-06-30 | $4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $8.12M 10-Q · filed 2020-08-05 | ||
| 2020-03-31 | $3.72M 10-Q · filed 2020-05-13 | |||
| 2017-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.61M derived: sum of 2 quarters · filed 2017-11-07 | $3.61M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.00M 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | $1.00M 10-Q · filed 2017-05-10 | |||
| 2016-09-30 | $5.00M 10-Q · filed 2017-11-07 | |||
| 2015-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$59.00K derived: sum of 2 quarters · filed 2016-11-09 | -$59.00K derived: sum of 3 quarters · filed 2016-11-09 | $36.20M 10-K · filed 2016-02-19 |
| 2015-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$3.00K derived: sum of 2 quarters · filed 2016-11-09 | $36.26M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $36.26M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $36.26M 10-Q · filed 2016-05-11 | |||
| 2014-12-31 | -$1.25M 10-K · filed 2016-02-19 |